Dongguang, China

Kuo Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kuo Zhang. Retrieved from https://idiyas.com/inventor/kuo-zhang-l7i2ml5v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kuo Zhang: Innovator in Humanized Anti-TRKA Antibodies

Introduction

Kuo Zhang is a prominent inventor based in Dongguang, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized anti-TRKA antibodies. His innovative work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Kuo Zhang holds a patent for "Humanized Anti-TRKA Antibodies and Uses Thereof." This patent represents a crucial advancement in the treatment of diseases associated with TRKA, showcasing his expertise and dedication to improving healthcare solutions. He has 1 patent to his name.

Career Highlights

Kuo Zhang is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to push the boundaries of pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the industry.

Collaborations

Kuo Zhang has worked alongside notable colleagues, including Zhiheng Ren and Junji Dong. Their combined efforts contribute to the innovative projects at Sunshine Lake Pharma Co., Ltd., fostering a collaborative environment that enhances research outcomes.

Conclusion

Kuo Zhang is a dedicated inventor whose work in humanized anti-TRKA antibodies exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for new therapeutic options, and his collaboration with esteemed colleagues further strengthens the impact of his research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…